Jubilant Pharmova Executive and Leadership Team

Harsher Singh, the Chief Executive Officer - Jubilant Radiopharma at Jubilant Pharmova, directs the specialized radiopharmaceutical division with a focus on diagnostic and therapeutic innovation. Overseeing complex supply chains for radioactive isotopes, the Chief Executive Officer - Jubilant Radiopharma ensures strict regulatory compliance across North American and European markets. This leadership role involves managing high-stakes partnerships with healthcare providers to improve patient access to critical imaging agents. By optimizing production workflows, Harsher Singh directly impacts the scalability of life-saving medical treatments. The Chief Executive Officer - Jubilant Radiopharma maintains rigorous quality standards to support the broader biopharmaceutical mission. Through strategic oversight of clinical development pipelines, Singh secures the competitive positioning of the radiopharma portfolio. This executive leadership drives long-term growth by aligning technical capabilities with evolving global healthcare demands, ultimately enhancing the therapeutic impact of the entire organization.

Ashish Mukkirwar, the President & Chief Financial Officer at Jubilant Pharmova, directs the financial strategy and capital allocation to support long-term biopharmaceutical growth. Overseeing fiscal planning and investor relations, the President & Chief Financial Officer ensures the company maintains a robust balance sheet for research investments. This leadership role involves managing complex financial reporting and risk assessment frameworks to protect shareholder value. By optimizing capital structures, Ashish Mukkirwar directly impacts the ability to fund large-scale clinical trials and infrastructure upgrades. The President & Chief Financial Officer collaborates with the board to define strategic priorities and evaluate potential market opportunities. Through disciplined cost management, Mukkirwar secures the financial health required for sustained innovation. This executive role requires deep analytical insight into global pharmaceutical market trends to guide resource distribution. Ultimately, the President & Chief Financial Officer drives the financial performance necessary to achieve the company's mission of improving patient outcomes.

Arul Ramakrishnan, the Chief Operating Officer at Jubilant Pharmova, directs all manufacturing operations and supply chain logistics to ensure seamless production cycles. Overseeing the integration of advanced pharmaceutical manufacturing technologies, the Chief Operating Officer maintains operational excellence across all production facilities. This leadership role involves coordinating cross-functional teams to optimize output efficiency and reduce lead times for essential medications. By implementing lean manufacturing principles, Arul Ramakrishnan directly impacts the cost-effectiveness of the company's biopharmaceutical offerings. The Chief Operating Officer monitors global distribution networks to guarantee consistent product availability for patients worldwide. Through rigorous process improvement initiatives, Ramakrishnan supports the company's commitment to high-quality standards. This executive role requires constant collaboration with research and development departments to scale new product launches effectively. Ultimately, the Chief Operating Officer drives the operational stability necessary for sustained market expansion and long-term organizational success.

Shantanu Jha, the Group Chief Human Resources Officer at Jubilant Pharmova, directs the global talent strategy and organizational development initiatives. Overseeing recruitment, retention, and leadership training, the Group Chief Human Resources Officer ensures the workforce possesses the technical expertise required for biopharmaceutical manufacturing. This leadership role involves fostering a culture of innovation and compliance across diverse international teams. By implementing performance management systems, Shantanu Jha directly impacts employee engagement and productivity levels. The Group Chief Human Resources Officer collaborates with executive leadership to align human capital strategies with the company's overarching business objectives. Through comprehensive workforce planning, Jha supports the scaling of operations in key geographic regions. This executive role requires constant adaptation to changing labor regulations and industry standards to maintain a competitive employer brand. Ultimately, the Group Chief Human Resources Officer drives the organizational health necessary to sustain the company's patient-focused mission.